BSE filing, BSE: 543787. Summary written from the filing by ALFA Finder's alert engine.
Macfos Ltd: key numbers
- Share price
- ₹1,120.00
- Market cap
- ₹1,160 Cr
- Revenue (annual)
- ₹308.8 Cr
- Net profit (annual)
- ₹25.64 Cr
- P/E (TTM)
- 45.2×Sector 23.0×
- Promoter holding
- 69.12%+0.00% QoQ
- FII holding
- 0.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Macfos Ltd
All →Macfos Q2 FY27 Results: Net Profit ₹7.4 Cr, Up 45.1% YoY
Macfos Ltd reported revenue from operations of ₹98.7 Cr (+44.1% YoY) and net profit of ₹7.4 Cr (+45.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹7.4 Cr · +45.1% YoY
Macfos Board Meeting Date
Macfos Limited scheduled a board meeting on 28th October 2026 to consider and approve its unaudited standalone and consolidated financial results.
Macfos Other Announcement
Macfos Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, as per SEBI disclosure requirements.
Macfos Annual General Meeting
Macfos Ltd filed its 9th AGM proceedings, clarifying a BSE portal OTP-related delay. Routine items including audited financials and director re-appointment were passed.
Macfos Annual General Meeting
Macfos Limited held its 09th Annual General Meeting on September 7, 2026. Shareholders approved the audited standalone and consolidated financial statements and re-appointed a director.
Macfos Annual Report
Macfos Limited has submitted its Annual Report for FY 2025-26, along with the notice for the upcoming 9th Annual General Meeting scheduled for September 7, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.